PubMed:32829416 JSON TXT

The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.

projects that include this document

Unselected / annnotation		Selected / annnotation
LitCovid-GlycoBiology (0) Inflammaging (2) GlyCosmos6-docs (0) Glycosmos6-GlycoEpitope (0) GlyCosmos6-Glycan-Motif-Structure (0) Glycosmos6-MAT (0) sentences (1) GlyCosmos6-Glycan-Motif-Image (0) Anatomy-MAT (0) GlyCosmos15-HP (0) mondo_disease (1) GlyCosmos15-docs (0) GlyCosmos15-Glycan (0) NCBITAXON (0) Glycosmos15-GlycoEpitope (0) Anatomy-UBERON (0) Glycosmos15-CL (0)